NIH Staff Faces Broader AIDS Testing

WASHINGTON—The National Institutes of Health is tightening monitoring and information programs for researchers and other staff who handle the AIDS virus. The new effort follows the announcement October 8 that a second worker has become infected, apparently in an accident at an contract facility. Some scien tists have also questioned whether current safety guidelines are adequate to deal with the dangers posed by working with the virus. The new procedures will require workers in the inst

Written byAmy Mcdonald
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON—The National Institutes of Health is tightening monitoring and information programs for researchers and other staff who handle the AIDS virus. The new effort follows the announcement October 8 that a second worker has become infected, apparently in an accident at an contract facility. Some scien tists have also questioned whether current safety guidelines are adequate to deal with the dangers posed by working with the virus. The new procedures will require workers in the institutes AIDS labs to participate in testing administered and funded by NIH or to sign a waiver indicating that they have been notified of the program and would rather be monitored by a private physician, said Robert McKinney, director of NIH’s Division of Safety. McKinney heads a group that is meeting weekly to iron out details.

Although the two reported infections occurred at off-campus labs handling highly concentrated preparations of the AIDS virus, NIH officials ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies